Global Crude Unfractionated Heparin (UFH) Market Research Report 2024(Status and Outlook)

Global Crude Unfractionated Heparin (UFH) Market Research Report 2024(Status and Outlook)



Report Overview:

Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.

The Global Crude Unfractionated Heparin (UFH) Market Size was estimated at USD 5194.87 million in 2023 and is projected to reach USD 9664.15 million by 2029, exhibiting a CAGR of 10.90% during the forecast period.

This report provides a deep insight into the global Crude Unfractionated Heparin (UFH) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Crude Unfractionated Heparin (UFH) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Crude Unfractionated Heparin (UFH) market in any manner.

Global Crude Unfractionated Heparin (UFH) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Bioiberica

Shenzhen Hepalink

Sanofi

Nanjing King-friend

Fengrun Biological Technology

Aspen Oss

Hebei Changshan Biochemical

Changzhou Qianhong

Hepac (Darling Ingredients)

Huaian MDC Pharmaceutical

Yantai Dongcheng Biochemicals

Market Segmentation (by Type)

Pig Intestine Mucosa Heparin

Bovine Heparin and Others

Market Segmentation (by Application)

Unfractionated Heparin (UFH)

Low-Molecular-Weight Heparin (LMWH)

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Crude Unfractionated Heparin (UFH) Market
  • Overview of the regional outlook of the Crude Unfractionated Heparin (UFH) Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Crude Unfractionated Heparin (UFH) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Crude Unfractionated Heparin (UFH)
1.2 Key Market Segments
1.2.1 Crude Unfractionated Heparin (UFH) Segment by Type
1.2.2 Crude Unfractionated Heparin (UFH) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Crude Unfractionated Heparin (UFH) Market Overview
2.1 Global Market Overview
2.1.1 Global Crude Unfractionated Heparin (UFH) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Crude Unfractionated Heparin (UFH) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Crude Unfractionated Heparin (UFH) Market Competitive Landscape
3.1 Global Crude Unfractionated Heparin (UFH) Sales by Manufacturers (2019-2024)
3.2 Global Crude Unfractionated Heparin (UFH) Revenue Market Share by Manufacturers (2019-2024)
3.3 Crude Unfractionated Heparin (UFH) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Crude Unfractionated Heparin (UFH) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Crude Unfractionated Heparin (UFH) Sales Sites, Area Served, Product Type
3.6 Crude Unfractionated Heparin (UFH) Market Competitive Situation and Trends
3.6.1 Crude Unfractionated Heparin (UFH) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Crude Unfractionated Heparin (UFH) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Crude Unfractionated Heparin (UFH) Industry Chain Analysis
4.1 Crude Unfractionated Heparin (UFH) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Crude Unfractionated Heparin (UFH) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Crude Unfractionated Heparin (UFH) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Crude Unfractionated Heparin (UFH) Sales Market Share by Type (2019-2024)
6.3 Global Crude Unfractionated Heparin (UFH) Market Size Market Share by Type (2019-2024)
6.4 Global Crude Unfractionated Heparin (UFH) Price by Type (2019-2024)
7 Crude Unfractionated Heparin (UFH) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Crude Unfractionated Heparin (UFH) Market Sales by Application (2019-2024)
7.3 Global Crude Unfractionated Heparin (UFH) Market Size (M USD) by Application (2019-2024)
7.4 Global Crude Unfractionated Heparin (UFH) Sales Growth Rate by Application (2019-2024)
8 Crude Unfractionated Heparin (UFH) Market Segmentation by Region
8.1 Global Crude Unfractionated Heparin (UFH) Sales by Region
8.1.1 Global Crude Unfractionated Heparin (UFH) Sales by Region
8.1.2 Global Crude Unfractionated Heparin (UFH) Sales Market Share by Region
8.2 North America
8.2.1 North America Crude Unfractionated Heparin (UFH) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Crude Unfractionated Heparin (UFH) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Crude Unfractionated Heparin (UFH) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Crude Unfractionated Heparin (UFH) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Crude Unfractionated Heparin (UFH) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bioiberica
9.1.1 Bioiberica Crude Unfractionated Heparin (UFH) Basic Information
9.1.2 Bioiberica Crude Unfractionated Heparin (UFH) Product Overview
9.1.3 Bioiberica Crude Unfractionated Heparin (UFH) Product Market Performance
9.1.4 Bioiberica Business Overview
9.1.5 Bioiberica Crude Unfractionated Heparin (UFH) SWOT Analysis
9.1.6 Bioiberica Recent Developments
9.2 Shenzhen Hepalink
9.2.1 Shenzhen Hepalink Crude Unfractionated Heparin (UFH) Basic Information
9.2.2 Shenzhen Hepalink Crude Unfractionated Heparin (UFH) Product Overview
9.2.3 Shenzhen Hepalink Crude Unfractionated Heparin (UFH) Product Market Performance
9.2.4 Shenzhen Hepalink Business Overview
9.2.5 Shenzhen Hepalink Crude Unfractionated Heparin (UFH) SWOT Analysis
9.2.6 Shenzhen Hepalink Recent Developments
9.3 Sanofi
9.3.1 Sanofi Crude Unfractionated Heparin (UFH) Basic Information
9.3.2 Sanofi Crude Unfractionated Heparin (UFH) Product Overview
9.3.3 Sanofi Crude Unfractionated Heparin (UFH) Product Market Performance
9.3.4 Sanofi Crude Unfractionated Heparin (UFH) SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Nanjing King-friend
9.4.1 Nanjing King-friend Crude Unfractionated Heparin (UFH) Basic Information
9.4.2 Nanjing King-friend Crude Unfractionated Heparin (UFH) Product Overview
9.4.3 Nanjing King-friend Crude Unfractionated Heparin (UFH) Product Market Performance
9.4.4 Nanjing King-friend Business Overview
9.4.5 Nanjing King-friend Recent Developments
9.5 Fengrun Biological Technology
9.5.1 Fengrun Biological Technology Crude Unfractionated Heparin (UFH) Basic Information
9.5.2 Fengrun Biological Technology Crude Unfractionated Heparin (UFH) Product Overview
9.5.3 Fengrun Biological Technology Crude Unfractionated Heparin (UFH) Product Market Performance
9.5.4 Fengrun Biological Technology Business Overview
9.5.5 Fengrun Biological Technology Recent Developments
9.6 Aspen Oss
9.6.1 Aspen Oss Crude Unfractionated Heparin (UFH) Basic Information
9.6.2 Aspen Oss Crude Unfractionated Heparin (UFH) Product Overview
9.6.3 Aspen Oss Crude Unfractionated Heparin (UFH) Product Market Performance
9.6.4 Aspen Oss Business Overview
9.6.5 Aspen Oss Recent Developments
9.7 Hebei Changshan Biochemical
9.7.1 Hebei Changshan Biochemical Crude Unfractionated Heparin (UFH) Basic Information
9.7.2 Hebei Changshan Biochemical Crude Unfractionated Heparin (UFH) Product Overview
9.7.3 Hebei Changshan Biochemical Crude Unfractionated Heparin (UFH) Product Market Performance
9.7.4 Hebei Changshan Biochemical Business Overview
9.7.5 Hebei Changshan Biochemical Recent Developments
9.8 Changzhou Qianhong
9.8.1 Changzhou Qianhong Crude Unfractionated Heparin (UFH) Basic Information
9.8.2 Changzhou Qianhong Crude Unfractionated Heparin (UFH) Product Overview
9.8.3 Changzhou Qianhong Crude Unfractionated Heparin (UFH) Product Market Performance
9.8.4 Changzhou Qianhong Business Overview
9.8.5 Changzhou Qianhong Recent Developments
9.9 Hepac (Darling Ingredients)
9.9.1 Hepac (Darling Ingredients) Crude Unfractionated Heparin (UFH) Basic Information
9.9.2 Hepac (Darling Ingredients) Crude Unfractionated Heparin (UFH) Product Overview
9.9.3 Hepac (Darling Ingredients) Crude Unfractionated Heparin (UFH) Product Market Performance
9.9.4 Hepac (Darling Ingredients) Business Overview
9.9.5 Hepac (Darling Ingredients) Recent Developments
9.10 Huaian MDC Pharmaceutical
9.10.1 Huaian MDC Pharmaceutical Crude Unfractionated Heparin (UFH) Basic Information
9.10.2 Huaian MDC Pharmaceutical Crude Unfractionated Heparin (UFH) Product Overview
9.10.3 Huaian MDC Pharmaceutical Crude Unfractionated Heparin (UFH) Product Market Performance
9.10.4 Huaian MDC Pharmaceutical Business Overview
9.10.5 Huaian MDC Pharmaceutical Recent Developments
9.11 Yantai Dongcheng Biochemicals
9.11.1 Yantai Dongcheng Biochemicals Crude Unfractionated Heparin (UFH) Basic Information
9.11.2 Yantai Dongcheng Biochemicals Crude Unfractionated Heparin (UFH) Product Overview
9.11.3 Yantai Dongcheng Biochemicals Crude Unfractionated Heparin (UFH) Product Market Performance
9.11.4 Yantai Dongcheng Biochemicals Business Overview
9.11.5 Yantai Dongcheng Biochemicals Recent Developments
10 Crude Unfractionated Heparin (UFH) Market Forecast by Region
10.1 Global Crude Unfractionated Heparin (UFH) Market Size Forecast
10.2 Global Crude Unfractionated Heparin (UFH) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Crude Unfractionated Heparin (UFH) Market Size Forecast by Country
10.2.3 Asia Pacific Crude Unfractionated Heparin (UFH) Market Size Forecast by Region
10.2.4 South America Crude Unfractionated Heparin (UFH) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Crude Unfractionated Heparin (UFH) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Crude Unfractionated Heparin (UFH) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Crude Unfractionated Heparin (UFH) by Type (2025-2030)
11.1.2 Global Crude Unfractionated Heparin (UFH) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Crude Unfractionated Heparin (UFH) by Type (2025-2030)
11.2 Global Crude Unfractionated Heparin (UFH) Market Forecast by Application (2025-2030)
11.2.1 Global Crude Unfractionated Heparin (UFH) Sales (Kilotons) Forecast by Application
11.2.2 Global Crude Unfractionated Heparin (UFH) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings